Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)
出版年份 2014 全文链接
标题
Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)
作者
关键词
-
出版物
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 92, Issue 6, Pages 527-536
出版商
Wiley
发表日期
2014-03-03
DOI
10.1111/ejh.12300
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients
- (2013) Laurent Pascal et al. BRITISH JOURNAL OF HAEMATOLOGY
- Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload
- (2012) F. Nolte et al. ANNALS OF HEMATOLOGY
- Deferasirox treatment for myelodysplastic syndromes: “real-life” efficacy and safety in a single-institution patient population
- (2012) Massimo Breccia et al. ANNALS OF HEMATOLOGY
- How I treat transfusional iron overload
- (2012) A. V. Hoffbrand et al. BLOOD
- Differential effects of the type of iron chelator on the absolute number of hematopoietic peripheral progenitors in patients with -thalassemia major
- (2012) G. L. Forni et al. HAEMATOLOGICA
- Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
- (2012) N. Gattermann et al. HAEMATOLOGICA
- Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion–Dependent Patients With Myelodysplastic Syndrome
- (2012) Alan F. List et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved survival in MDS patients receiving iron chelation therapy – A matched pair analysis of 188 patients from the Düsseldorf MDS registry
- (2012) Judith Neukirchen et al. LEUKEMIA RESEARCH
- Iron overload impairs proliferation of erythroid progenitors cells (BFU-E) from patients with myelodysplastic syndromes
- (2012) Julia Hartmann et al. LEUKEMIA RESEARCH
- Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome
- (2011) Hussam Ghoti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Deferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange
- (2011) Norbert Gattermann et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasirox
- (2011) Florian Nolte et al. LEUKEMIA RESEARCH
- Iron overload in MDS—pathophysiology, diagnosis, and complications
- (2010) Norbert Gattermann et al. ANNALS OF HEMATOLOGY
- Deferasirox is a powerful NF- B inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging
- (2010) E. Messa et al. HAEMATOLOGICA
- Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes
- (2010) H. Ghoti et al. HAEMATOLOGICA
- Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome
- (2010) M. G. Della Porta et al. HAEMATOLOGICA
- Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM
- (2010) Christian Rose et al. LEUKEMIA RESEARCH
- Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
- (2010) Norbert Gattermann et al. LEUKEMIA RESEARCH
- Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes
- (2010) Peter L. Greenberg et al. LEUKEMIA RESEARCH
- Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines
- (2010) V. Santini et al. LEUKEMIA RESEARCH
- What are RBC-transfusion-dependence and -independence?
- (2010) R.P. Gale et al. LEUKEMIA RESEARCH
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts
- (2009) Jaroslav Cermak et al. LEUKEMIA RESEARCH
- Consensus statement on iron overload in myelodysplastic syndromes
- (2008) John M. Bennett et al. AMERICAN JOURNAL OF HEMATOLOGY
- Deferasirox in MDS patients with transfusion-caused iron overload—a phase-II study
- (2008) Georgia Metzgeroth et al. ANNALS OF HEMATOLOGY
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
- (2008) D. E. Rollison et al. BLOOD
- Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias
- (2008) A. A. Di Tucci et al. HAEMATOLOGICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now